These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3126626)

  • 1. Glibenclamide improves the response to insulin treatment in non-insulin-dependent diabetics with second failure to sulfonylurea therapy.
    Lins PE; Lundblad S; Persson-Trotzig E; Adamson U
    Acta Med Scand; 1988; 223(2):171-9. PubMed ID: 3126626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics.
    Groop L; Wåhlin-Boll E; Groop PH; Tötterman KJ; Melander A; Tolppanen EM; Fyhrqvist F
    Eur J Clin Pharmacol; 1985; 28(6):697-704. PubMed ID: 3933984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glibenclamide and glipizide in maturity onset diabetes. A double-blind cross-over study.
    Blohmé G; Waldenström J
    Acta Med Scand; 1979; 206(4):263-7. PubMed ID: 116480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of combined treatment with glibenclamide and insulin in secondary sulfonylurea failure. A controlled multicenter double-blind clinical trial].
    Bachmann W; Lotz N; Mehnert H; Rosak C; Schöffling K
    Dtsch Med Wochenschr; 1988 Apr; 113(16):631-6. PubMed ID: 3129273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sulphonylurea therapy on insulin sensitivity in non insulin dependent diabetics.
    Khandekar S; Sethi BK; Dash RJ
    J Assoc Physicians India; 1990 Jul; 38(7):469-71. PubMed ID: 2127273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics.
    Groop L; Harno K
    Acta Endocrinol Suppl (Copenh); 1980; 239():44-52. PubMed ID: 6776763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion from low-dose insulin therapy to glipizide in patients with non-insulin-dependent diabetes mellitus.
    Rosenstock J; Meisel A; Raskin P
    Am J Med; 1987 Sep; 83(3A):10-5. PubMed ID: 3307402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term randomized placebo-controlled double-blind therapeutic comparison of glipizide and glyburide. Glycemic control and insulin secretion during 15 months.
    Birkeland KI; Furuseth K; Melander A; Mowinckel P; Vaaler S
    Diabetes Care; 1994 Jan; 17(1):45-9. PubMed ID: 8112188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin and sulphonylurea in the therapy of type 2 diabetes.
    Sotaniemi EA; Vierimaa E; Huupponen R; Karvonen I; Vuoti MJ; Rytömaa K
    Diabetes Res Clin Pract; 1990 Mar; 8(3):243-51. PubMed ID: 2111239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of insulin with glipizide increases peripheral glucose disposal in secondary failure type 2 diabetic patients.
    Simpson HC; Sturley R; Stirling CA; Reckless JP
    Diabet Med; 1990 Feb; 7(2):143-7. PubMed ID: 2137755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy of glibenclamide and insulin in NIDDM patients with secondary failure to oral drugs.
    Mohan V; Snehalatha C; Ramachandran A; Viswanathan M
    J Assoc Physicians India; 1990 Aug; 38(8):537-41. PubMed ID: 2123183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect on metabolic control of second-generation sulfonylurea drugs in patients with NIDDM after secondary failure to first-generation agents.
    Sami T; Kabadi UM; Moshiri S
    J Fam Pract; 1996 Oct; 43(4):370-4. PubMed ID: 8874372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical comparison of glipizide and glyburide.
    Schmitt JK
    Diabetes Care; 1989 Jan; 12(1):39. PubMed ID: 2496963
    [No Abstract]   [Full Text] [Related]  

  • 14. Transient effect of the combination of insulin and sulfonylurea (glibenclamide) on glycemic control in non-insulin dependent diabetics poorly controlled with insulin alone.
    Groop L; Harno K; Nikkilä EA; Pelkonen R; Tolppanen EM
    Acta Med Scand; 1985; 217(1):33-9. PubMed ID: 3919531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD
    Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glyburide and glipizide in treatment of diabetic patients with secondary failures to tolazamide or chlorpropamide.
    Lev JD; Zeidler A; Kumar D
    Diabetes Care; 1987; 10(6):679-82. PubMed ID: 3123183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined insulin-glibenclamide therapy of NIDDM patients in primary health care. A follow-up study of its compliance and efficacy and a review of the literature.
    Liu D; Wettergren M; Lins PE; Adamson U
    Scand J Prim Health Care; 1990 Dec; 8(4):213-7. PubMed ID: 2126639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of bedtime NPH or preprandial regular insulin combined with glibenclamide in secondary sulfonylurea failure.
    Landstedt-Hallin L; Adamson U; Arner P; Bolinder J; Lins PE
    Diabetes Care; 1995 Aug; 18(8):1183-6. PubMed ID: 7587856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.